Indoco Remedies Limited (NSE:INDOCO)
India
· Delayed Price · Currency is INR 245.46
+2.79 (1.15%)
May 23, 2025, 1:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Pharmaceutical | 17.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | 10.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services | 373.06M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services Growth | -39.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exchange Gain/(Loss) (Net) (Other than Considered in Finance Cost) | 186.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exchange Gain/(Loss) (Net) (Other than Considered in Finance Cost) Growth | -9.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Export Incentives | 92.23M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Export Incentives Growth | 24.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scrap | 12.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scrap Growth | 93.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| India | 9.68B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | 13.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 8.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 3.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|